NCT00989625View on ClinicalTrials.gov

A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 4, 2008

Primary Completion Date

September 10, 2009

Study Completion Date

September 10, 2009

Conditions
Migraine Disorders
Interventions
DRUG

This is a pharmacokinetic study (Treximet)

This is a pharmacokinetic study to collect PK samples from subject after single dose.

DRUG

This is a pharmacokinetic study (Treximet)

This is a pharmacokinetic study to collect PK samples from subject after single dose.

DRUG

This is a pharmacokinetic study (Treximet)

This is a pharmacokinetic study to collect PK samples from subject after single dose.

Trial Locations (3)

38105

GSK Investigational Site, Memphis

40202

GSK Investigational Site, Louisville

67207

GSK Investigational Site, Wichita

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY